 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$2.14 |
$2.14 |
$1.94 |
$1.97 |
382.90K | | 04/16/2024 |
$1.99 |
$1.99 |
$1.86 |
$1.86 |
335.80K | | 04/17/2024 |
$1.84 |
$1.86 |
$1.76 |
$1.76 |
585.20K | | 04/18/2024 |
$1.77 |
$1.79 |
$1.72 |
$1.73 |
198.80K | | 04/19/2024 |
$1.72 |
$1.75 |
$1.64 |
$1.67 |
505.60K |
|
|
| CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab. | |
|
CytomX Therapeutics (CTMX) has the following price history information. Looking back at CTMX historical stock prices for the last five trading days, on April 15, 2024, CTMX opened at $2.14, traded as high as $2.14 and as low as $1.94, and closed at $1.97. Trading volume was a total of 382.90K shares. On April 16, 2024, CTMX opened at $1.99, traded as high as $1.99 and as low as $1.86, and closed at $1.86. Trading volume was a total of 335.80K shares. On April 17, 2024, CTMX opened at $1.84, traded as high as $1.86 and as low as $1.76, and closed at $1.76. Trading volume was a total of 585.20K shares. On April 18, 2024, CTMX opened at $1.77, traded as high as $1.79 and as low as $1.72, and closed at $1.73. Trading volume was a total of 198.80K shares. On April 19, 2024, CTMX opened at $1.72, traded as high as $1.75 and as low as $1.64, and closed at $1.67. Trading volume was a total of 505.60K shares.
CTMX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CytomX Therapeutics shares, starting with a $10,000 purchase of CTMX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/09/2015 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$12.40 |
|
| End price/share: |
$1.67 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-86.53% |
|
| Average Annual Total Return: |
-20.94% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,346.29 |
|
| Years: |
8.53 |
|
|
|
| Date |
Close |
| 04/15/2024 | $1.97 | | 04/16/2024 | $1.86 | | 04/17/2024 | $1.76 | | 04/18/2024 | $1.73 | | 04/19/2024 | $1.67 |
|
|
Free CTMX Email Alerts:
